Sweden
# |
Name |
Free Cash Flow Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 0.71
|
Dec. 31, 2023 | USD 20.58 | 0.68% |
|
Sweden |
|
2 |
USD 0.58
|
Dec. 31, 2023 | USD 16.63 | 0.49% |
|
Sweden |
|
3 |
USD 0.47
|
Dec. 31, 2023 | USD 18.25 | 2.79% |
|
Sweden |
|
4 |
USD 0.46
|
Dec. 31, 2023 | USD 18.76 | 3.89% |
|
Sweden |
|
5 |
USD 0.38
|
Dec. 31, 2023 | USD 12.08 | 1.50% |
|
Sweden |
|
6 |
USD 0.37
|
Dec. 31, 2023 | USD 9.75 | -0.95% |
|
Sweden |
|
7 |
USD 0.34
|
Dec. 31, 2023 | USD 11.98 | -2.51% |
|
Sweden |
|
8 |
USD 0.34
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
9 |
USD 0.27
|
Dec. 31, 2023 | USD 31.10 | 0.68% |
|
Sweden |
|
10 |
USD 0.27
|
Dec. 31, 2023 | USD 4.99 | 0.68% |
|
Sweden |
|
11 |
USD 0.19
|
April 30, 2024 | USD 5.39 | -0.39% |
|
Sweden |
|
12 |
USD 0.08
|
Dec. 31, 2023 | USD 2.09 | -2.04% |
|
Sweden |
|
13 |
USD 0.05
|
Dec. 31, 2023 | USD 2.57 | -0.02% |
|
Sweden |
|
14 |
USD 0.03
|
Dec. 31, 2023 | USD 0.14 | 1.34% |
|
Sweden |
|
15 |
USD 0.00
|
Dec. 31, 2023 | USD 0.11 | 4.03% |
|
Sweden |
|
16 |
USD 0.00
|
Dec. 31, 2023 | USD 3.31 | 2.33% |
|
Sweden |
|
17 |
USD -0.01
|
Dec. 31, 2023 | USD 0.25 | 0.32% |
|
Sweden |
|
18 |
USD -0.01
|
Dec. 31, 2023 | USD 0.11 | 1.51% |
|
Sweden |
|
19 |
USD -0.02
|
Dec. 31, 2023 | USD 0.80 | 0.68% |
|
Sweden |
|
20 |
USD -0.02
|
Dec. 31, 2023 | USD 0.15 | -2.28% |
|
Sweden |
|
21 |
USD -0.03
|
Dec. 31, 2023 | USD 0.93 | -6.21% |
|
Sweden |
|
22 |
USD -0.03
|
Dec. 31, 2023 | USD 1.01 | -1.50% |
|
Sweden |
|
23 |
USD -0.03
|
Dec. 31, 2023 | USD 0.20 | 1.12% |
|
Sweden |
|
24 |
USD -0.04
|
Dec. 31, 2023 | USD 0.27 | -5.32% |
|
Sweden |
|
25 |
USD -0.04
|
Dec. 31, 2023 | USD 32.97 | -0.61% |
|
Sweden |
|
26 |
USD -0.04
|
Dec. 31, 2023 | USD 0.43 | -0.78% |
|
Sweden |
|
27 |
USD -0.04
|
Dec. 31, 2023 | USD 0.84 | -0.17% |
|
Sweden |
|
28 |
USD -0.05
|
Dec. 31, 2023 | USD 0.09 | 1.68% |
|
Sweden |
|
29 |
USD -0.07
|
Dec. 31, 2023 | USD 1.88 | 0.68% |
|
Sweden |
|
30 |
USD -0.08
|
Dec. 31, 2023 | USD 0.08 | 2.99% |
|
Sweden |
|
31 |
USD -0.08
|
Dec. 31, 2023 | USD 0.89 | 14.73% |
|
Sweden |
|
32 |
USD -0.08
|
Dec. 31, 2023 | USD 0.61 | 0.68% |
|
Sweden |
|
33 |
USD -0.08
|
Dec. 31, 2023 | USD 0.18 | 4.90% |
|
Sweden |
|
34 |
USD -0.08
|
Dec. 31, 2023 | USD 0.29 | 0.68% |
|
Sweden |
|
35 |
USD -0.09
|
Aug. 31, 2024 | USD 0.22 | -6.29% |
|
Sweden |
|
36 |
USD -0.09
|
Dec. 31, 2023 | USD 0.27 | 3.36% |
|
Sweden |
|
37 |
USD -0.10
|
Dec. 31, 2023 | USD 3.41 | 3.24% |
|
Sweden |
|
38 |
USD -0.10
|
Dec. 31, 2023 | USD 0.11 | 1.48% |
|
Sweden |
|
39 |
USD -0.10
|
Dec. 31, 2023 | USD 0.13 | -10.15% |
|
Sweden |
|
40 |
USD -0.11
|
Dec. 31, 2023 | USD 0.52 | 0.51% |
|
Sweden |
|
41 |
USD -0.11
|
Dec. 31, 2023 | USD 0.20 | 2.06% |
|
Sweden |
|
42 |
USD -0.11
|
Aug. 31, 2023 | USD 0.30 | -1.39% |
|
Sweden |
|
43 |
USD -0.11
|
Dec. 31, 2023 | USD 1.01 | 1.76% |
|
Sweden |
|
44 |
USD -0.12
|
April 30, 2024 | USD 1.60 | -0.43% |
|
Sweden |
|
45 |
USD -0.14
|
Aug. 31, 2024 | USD 1.61 | 0.34% |
|
Sweden |
|
46 |
USD -0.14
|
Dec. 31, 2023 | USD 28.64 | 0.87% |
|
Sweden |
|
47 |
USD -0.15
|
Dec. 31, 2023 | USD 0.21 | 0.68% |
|
Sweden |
|
48 |
USD -0.15
|
Dec. 31, 2023 | USD 0.16 | -1.51% |
|
Sweden |
|
49 |
USD -0.17
|
Dec. 31, 2023 | USD 0.15 | 0.09% |
|
Sweden |
|
50 |
USD -0.17
|
Dec. 31, 2023 | USD 3.19 | 2.10% |
|
Sweden |
The Biotechnology company in Sweden with the highest Free Cash Flow Per Share is RaySearch Laboratories AB (publ) (Stockholm Stock Exchange: RAY-B.ST) at USD 0.71.
The Biotechnology company in Sweden with the lowest Free Cash Flow Per Share is Qlife Holding AB (publ) (Stockholm Stock Exchange: QLIFE.ST) at USD -20.35.
The top 10 Biotechnology companies in Sweden by Free Cash Flow Per Share are RaySearch Laboratories AB (publ), Getinge AB (publ), Vitrolife AB (publ), CellaVision AB (publ), AddLife AB (publ), BioGaia AB (publ), Biotage AB (publ), BioArctic AB (publ), Probi AB (publ) and I-Tech AB.
The bottom 10 Biotechnology companies in Sweden by Free Cash Flow Per Share are Qlife Holding AB (publ), Clinical Laserthermia Systems AB (publ), Hansa Biopharma AB (publ), Guard Therapeutics International AB (publ), Moberg Pharma AB (publ), Xspray Pharma AB (publ), Qlucore Ab (Publ), Infant Bacterial Therapeutics AB (publ), Mendus AB (publ) and Devyser Diagnostics AB (publ).